BrdU labeling of multipotent progenitors in bone marrow and blood after CY/G-CSF mobilization in the presence of BrdU
Tissue . | Multipotent progenitor population . | Experiment no. . | BrdU+ cells/all calls . | |
---|---|---|---|---|
Ratio . | Percentage . | |||
Bone marrow | Thy-1.1loSca-1+ Lin−c-Kit+ | 1 | 555/557 | 99.6 |
2 | 354/357 | 99.2 | ||
3 | 342/347 | 98.6 | ||
mean | 99.1 ± 0.5 | |||
Blood | Thy-1.1loSca-1+ Lin−c-Kit+ | 2 | 191/194 | 98.5 |
Thy-1.1loSca-1+ Lin−/loc-Kit+ | 3 | 179/183 | 97.8 |
Tissue . | Multipotent progenitor population . | Experiment no. . | BrdU+ cells/all calls . | |
---|---|---|---|---|
Ratio . | Percentage . | |||
Bone marrow | Thy-1.1loSca-1+ Lin−c-Kit+ | 1 | 555/557 | 99.6 |
2 | 354/357 | 99.2 | ||
3 | 342/347 | 98.6 | ||
mean | 99.1 ± 0.5 | |||
Blood | Thy-1.1loSca-1+ Lin−c-Kit+ | 2 | 191/194 | 98.5 |
Thy-1.1loSca-1+ Lin−/loc-Kit+ | 3 | 179/183 | 97.8 |
Bone marrow (BM) and blood (pooled from 20 mice in experiment 1 and 10 mice in experiments 2 and 3) were obtained from animals treated with BrdU and CY/G-CSF (day + 4) and prepared for flow cytometry. Progenitors were double-sorted onto glass slides coated with tissue adhesive. Cells were lysed, and DNA was denatured and stained with anti-BrdU antibodies, which were visualized by immunofluorescence microscopy (see “Materials and methods”). BrdU+ and BrdU− cells were scored, and ratios were made of BrdU+ cells/total cells counted. The mean of the 3 BM experiments is expressed ± SD.